UPDATED: Senior FDA official refutes uniQure's claims amid controversy over Huntington's gene therapy
Fuente:
FierceBiotech
In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy for Huntington’s disease.